PLCL2 and prostate carcinoma: Interestingly, a previous study identified PLCL2 as part of a 23-gene expression panel that predicts metastatic lethal prostate cancer outcomes in patients with localised disease treated surgically [36] thus, further strengthening the possible association of this circRNA with prostate cancer.